Clinical Trials · NCT04179734

Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder

Phase
Phase 4
Recruitment status
Completed
Sponsor
Imperial College Healthcare NHS Trust
Enrollment
40
Start date
Oct 2019
Locations
1 site, United Kingdom
Primary endpoint
Changes in Blood Oxygen Level Dependent (BOLD) Signal Change on Functional MRI
View PT-141 compound reference